Rnf157-KO 基因敲除小鼠

1. Zhang, Zunyi, Chen, Weixun, Luo, Chu, Zhang, Wei. 2022. Exploring a four-gene risk model based on doxorubicin resistance-associated lncRNAs in hepatocellular carcinoma. In Frontiers in pharmacology, 13, 1015842. doi:10.3389/fphar.2022.1015842. https://pubmed.ncbi.nlm.nih.gov/36457707/

2. Kosacka, J, Nowicki, M, Paeschke, S, Blüher, M, Klöting, N. 2018. Up-regulated autophagy: as a protective factor in adipose tissue of WOKW rats with metabolic syndrome. In Diabetology & metabolic syndrome, 10, 13. doi:10.1186/s13098-018-0317-6. https://pubmed.ncbi.nlm.nih.gov/29507613/

3. Lin, Nuan, Lin, Jia-Zhe, Tanaka, Yoshiaki, Sun, Pingnan, Zhou, Xiaoling. . Identification and validation of a five-lncRNA signature for predicting survival with targeted drug candidates in ovarian cancer. In Bioengineered, 12, 3263-3274. doi:10.1080/21655979.2021.1946632. https://pubmed.ncbi.nlm.nih.gov/34224310/

4. Dogan, Taner, Gnad, Florian, Chan, Jocelyn, Hoeflich, Klaus P, Hatzivassiliou, Georgia. 2017. Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle. In The Journal of biological chemistry, 292, 14311-14324. doi:10.1074/jbc.M117.792754. https://pubmed.ncbi.nlm.nih.gov/28655764/